VKTX
Viking Therapeutics, Inc.
Stock
$29.94−0.57 (−1.87%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $41M
- YoY, 2025
- +37.4%
- 5-year CAGR
- +47.6%
- 10-year CAGR
- +31.7%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $41M | +37.4% |
| 2024 | $30M | +77.4% |
| 2023 | $17M | +93.1% |
| 2022 | $8.7M | +42.2% |
| 2021 | $6.1M | +4.8% |
| 2020 | $5.8M | +55.4% |
| 2019 | $3.7M | +43.5% |
| 2018 | $2.6M | +79.7% |
| 2017 | $1.5M | −19.1% |
| 2016 | $1.8M | −31.0% |
| 2015 | $2.6M | +41,470.0% |
| 2014 | $6K | — |